Li Y. et al. (2020) have observed that BACE1-AS levels are elevated in the substantia nigra of a rat model of PD, whereas down-regulated BACE1-AS decreases levels of α-syn, inducible nitric oxide synthase, and glutamine levels. Here, BACE1 is linked to Parkinson disease.